Franklin Resources Inc Crispr Therapeutics Ag Transaction History

Franklin Resources Inc

$313 Billion
Q2 2024

A detailed history of Franklin Resources Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Franklin Resources Inc holds 6,297 shares of CRSP stock, worth $326,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,297

Previous 6,274 0.37%

Holding current value

$326,688

Previous $427,000 20.37%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$51.17 - $68.18 $1,176 - $1,568	23 Added 0.37%	6,297 $340,000
Q1 2024 May 13, 2024	BUY	$60.67 - $89.12 $19,353 - $28,429	319 Added 5.36%	6,274 $427,000
Q4 2023 Feb 09, 2024	SELL	$38.62 - $72.18 $8.78 Million - $16.4 Million	-227,444 Reduced 97.45%	5,955 $372,000
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $9,123 - $11,859	201 Added 0.09%	233,399 $10.6 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $1,521 - $2,371	35 Added 0.02%	233,198 $13.1 Million
Q1 2023 May 12, 2023	SELL	$41.0 - $56.12 $2.5 Million - $3.42 Million	-60,908 Reduced 20.71%	233,163 $10.5 Million
Q4 2022 Feb 10, 2023	SELL	$39.19 - $65.67 $74,500 - $124,838	-1,901 Reduced 0.64%	294,071 $12 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $203,218 - $278,652	3,326 Added 1.14%	295,972 $19.3 Million
Q2 2022 Aug 11, 2022	SELL	$43.23 - $73.83 $13,530 - $23,108	-313 Reduced 0.11%	292,646 $17.8 Million
Q1 2022 May 13, 2022	SELL	$53.19 - $79.24 $1.04 Million - $1.55 Million	-19,544 Reduced 6.25%	292,959 $18.4 Million
Q4 2021 Feb 11, 2022	SELL	$70.09 - $111.29 $470,444 - $746,978	-6,712 Reduced 2.1%	312,503 $23.7 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $278,255 - $395,515	2,525 Added 0.8%	319,215 $35.7 Million
Q2 2021 Aug 13, 2021	SELL	$100.84 - $161.89 $51.7 Million - $83 Million	-512,664 Reduced 61.81%	316,690 $51.3 Million
Q1 2021 May 13, 2021	BUY	$110.72 - $210.04 $475,210 - $901,491	4,292 Added 0.52%	829,354 $101 Million
Q4 2020 Feb 10, 2021	SELL	$79.67 - $173.23 $6.11 Million - $13.3 Million	-76,751 Reduced 8.51%	825,062 $126 Million
Q3 2020 Nov 12, 2020	BUY	$78.5 - $100.64 $179,922 - $230,666	2,292 Added 0.25%	901,813 $75.4 Million
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $17.6 Million - $34.7 Million	456,574 Added 103.08%	899,521 $83.6 Million
Q1 2020 May 13, 2020	BUY	$33.68 - $62.53 $245,965 - $456,656	7,303 Added 1.68%	442,947 $18.8 Million
Q4 2019 Feb 12, 2020	BUY	$36.68 - $73.13 $404,617 - $806,697	11,031 Added 2.6%	435,644 $26.5 Million
Q1 2019 May 14, 2019	SELL	$28.02 - $40.87 $1.53 Million - $2.24 Million	-54,750 Reduced 11.42%	424,613 $15.2 Million
Q3 2018 Nov 13, 2018	SELL	$44.35 - $65.71 $10.8 Million - $15.9 Million	-242,420 Reduced 33.59%	479,363 $21.3 Million
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $428,331 - $739,579	10,050 Added 1.41%	721,783 $42.4 Million
Q1 2018 May 10, 2018	SELL	$23.52 - $58.17 $1.95 Million - $4.82 Million	-82,800 Reduced 10.42%	711,733 $32.5 Million
Q4 2017 Feb 14, 2018	BUY	$16.95 - $23.48 $1.11 Million - $1.53 Million	65,200 Added 8.94%	794,533 $18.7 Million
Q3 2017 Nov 13, 2017	BUY	$16.75 - $20.66 $12.2 Million - $15.1 Million	729,333	729,333 $13 Million

Others Institutions Holding CRSP

# of Institutions

499

Shares Held

56.8M

Call Options Held

1.7M

Put Options Held

1.8M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Crispr Therapeutics Ag Transaction History